Shinshu University Hospital

Nagano 390-8621

3 studies enrolling now · 14 studies all time

What they study most

Amyloid Cardiomyopathy, Amyloidosis, Branch Retinal Vein Occlusion, Cardiomyopathies, Central Retinal Vein Occlusion, Cold Agglutinin Disease, Diabetes Mellitus, Type 2, Diabetic Macular Edema, Duchenne Muscular Dystrophy, Epileptic Encephalopathy, Follicular Lymphoma, Heart Diseases

Studies at this site

• A First-in-human Study of S230815 in Pediatric Participants With KCNT1-related Developmental and Epileptic Encephalopathy — Recruiting now
• Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant — Recruiting now
• A Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM) — Running, not enrolling
• Expanded Access Study for the Treatment of Patients With Commercially Out-of-Specification Axicabtagene Ciloleucel — Available (expanded access)
• A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products — Running, not enrolling
• A Heart Disease Study of Semaglutide in Patients With Type 2 Diabetes — Completed
• A Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Patients With Cold Agglutinin Disease (CAD) — Completed
• A Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Neovascular Age-Related Macular Degeneration — Completed
• A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (TENAYA) — Completed
• Long-term Safety of Tafamidis in Subjects With Transthyretin Cardiomyopathy — Completed
• A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Central Retinal or Hemiretinal Vein Occlusion — Completed
• Strategic Management to Optimize Response To Cardiac Resynchronization Therapy — Completed
• Clinical Trial to Evaluate the Efficacy, Safety, and Tolerability of RO7239361 in Ambulatory Boys With Duchenne Muscular Dystrophy — Completed
• Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy — Completed